Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PANSKY, A.
Right arrow Articles by HILDEBRAND, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PANSKY, A.
Right arrow Articles by HILDEBRAND, P.
J Am Soc Nephrol 11:1409-1418, 2000
© 2000 American Society of Nephrology

Gastrin Releasing Peptide-Preferring Bombesin Receptors Mediate Growth of Human Renal Cell Carcinoma

ANDREAS PANSKY*, ANDREAS DE WEERTH{dagger}, ELIZAVETA FASLER-KAN*, JEAN-LOUIS BOULAY*, MARTINA SCHULZ{dagger}, SYLVIA KETTERER*, CRISTIN SELCK{dagger}, CHRISTOPH BEGLINGER*, TAMMO VON SCHRENCK{dagger} and PIUS HILDEBRAND*

* Department of Research and Division of Gastroenterology, University Hospital, Basel, Switzerland
{dagger} Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg, Germany.

Correspondence to Dr. Pius Hildebrand, Department of Research and Division of Gastroenterology, University Hospital, CH-4031 Basel, Switzerland. Phone: +41 612 652343; Fax: +41 612 652350; E-mail: pius.hildebrand{at}unibas.ch

Abstract. Bombesin-like peptides typically act as neurotransmitters along the brain-gut axis and as growth factors in various human tissues. The present study demonstrates the expression of gastrin releasing peptide (GRP)-preferring bombesin receptors in human renal cell carcinoma but not in normal kidney tissue. The expression of GRP receptors was characterized at the mRNA level by reverse transcription-PCR, as well as at the protein level by binding of 125I-[Tyr4] bombesin to membranes prepared from tumor tissue (Kd 0.3 nM) and healthy kidney tissue from the same four patients. GRP receptors were also demonstrated in four human kidney carcinoma cell lines (A-498, CAKI-1, CAKI-2, and ACHN). The effects of bombesin/GRP agonists and/or antagonists on growth were investigated in vitro on CAKI-2 cells, which expressed large amounts of GRP receptors. Cell numbers stimulated by 10% fetal calf serum were significantly stimulated by interleukin-1ß (control) and GRP-7 (10-7 M), both in the range of 136 to 148%; addition of the GRP receptor antagonist acetyl-GRP(20-27) (10-6 M) completely reversed this effect. Bombesin alone (10-6 M) significantly stimulated CAKI-2 cells (129%) cultured with 0.5% fetal calf serum, whereas another antagonist, D-Phe6,Leu13,(CH2NH)Leu14 bombesin(6-14) (1 µM), alone did not inhibit growth, thus excluding an autocrine mechanism. These results indicate for the first time that malignant transformation of human kidney tissue into renal cell carcinoma is accompanied by novel expression of GRP receptors. Bombesin-like peptides might act as mitogens in these carcinomas, and they might be useful as diagnostic or therapeutic tools such as tumor imaging or internal radiotherapy.




This article has been cited by other articles:


Home page
 Ann OncolHome page
D. Cornelio, R Roesler, and G Schwartsmann
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
Ann. Onc., September 1, 2007; 18(9): 1457 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Dumesny, J. C. Whitley, G. S. Baldwin, A. S. Giraud, and A. Shulkes
Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F578 - F585.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. C. Reubi
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Endocr. Rev., August 1, 2003; 24(4): 389 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. C. Reubi, S. Wenger, J. Schmuckli-Maurer, J.-C. Schaer, and M. Gugger
Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[D-TYR6, {beta}-ALA11, PHE13, NLE14] Bombesin(6-14)
Clin. Cancer Res., April 1, 2002; 8(4): 1139 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. N. Lango, K. F. Dyer, V. W. Y. Lui, W. E. Gooding, C. Gubish, J. M. Siegfried, and J. R. Grandis
Gastrin-Releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck
J Natl Cancer Inst, March 6, 2002; 94(5): 375 - 383.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673